Hans-Peter Ostler

Hans-Peter Ostler is an experienced professional with a diverse background in leadership roles across various organizations. Currently serving as Ordförande and Styrelseledamot at Encare and Belayit, Ostler also holds significant positions such as Ordförande and Vice ordförande at Alligator Bioscience AB and Ordförande at Oblique Therapeutics AB, which focuses on drug discovery and development. Additional responsibilities include leading as Ordförande at Vakona AB and NH3 GREENTECH, and Styrelseordförande at Hoodin, alongside roles in Opsy and Storytel. Notably, Ostler has served as Interim Chief Executive Officer at TikoMed AB. With an education from the University of Gothenburg, Ostler's expertise spans biotechnology, risk management, and innovation.